Cost-effectiveness analysis of PCV20 to prevent pneumococcal disease in the Canadian pediatric population

• Main Authors: Derek Lytle (Author), Ana Gabriela Grajales Beltrán (Author), Johnna Perdrizet (Author), Nassim Ait Yahia (Author), Alejandro Cane (Author), Benjamin Yarnoff (Author), Ruth Chapman (Author)
• Format: Book
• Published: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

This study assessed the cost-effectiveness of the 20-valent pneumococcal conjugate vaccine (PCV20) in Canadian infants aged <2 years versus the standard of care (SoC), a 13-valent pneumococcal conjugate vaccine (PCV13), or a potential 15-valent pneumococcal conjugate vaccine (PCV15). A decision-a...